1. Home
  2. BFC vs ANAB Comparison

BFC vs ANAB Comparison

Compare BFC & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bank First Corporation

BFC

Bank First Corporation

N/A

Current Price

$153.63

Market Cap

1.6B

Sector

Finance

ML Signal

N/A

Logo AnaptysBio Inc.

ANAB

AnaptysBio Inc.

N/A

Current Price

$55.84

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BFC
ANAB
Founded
1894
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
BFC
ANAB
Price
$153.63
$55.84
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$157.00
$71.67
AVG Volume (30 Days)
54.4K
356.0K
Earning Date
04-16-2026
05-08-2026
Dividend Yield
1.52%
N/A
EPS Growth
11.23
91.02
EPS
3.99
N/A
Revenue
N/A
$234,603,000.00
Revenue This Year
$58.67
N/A
Revenue Next Year
$2.01
$52.14
P/E Ratio
$37.68
N/A
Revenue Growth
N/A
157.01
52 Week Low
$119.08
$17.11
52 Week High
$159.10
$73.30

Technical Indicators

Market Signals
Indicator
BFC
ANAB
Relative Strength Index (RSI) 53.23 45.73
Support Level $149.89 $53.46
Resistance Level $159.10 $57.70
Average True Range (ATR) 3.39 2.43
MACD -0.53 -0.20
Stochastic Oscillator 52.09 18.14

Price Performance

Historical Comparison
BFC
ANAB

About BFC Bank First Corporation

Bank First Corp is a United States-based company engaged in providing financial services, a full range of consumer and commercial financial institution services to individuals and businesses, including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: